NFG
CATX icon

Norris Financial Group’s Perspective Therapeutics CATX Stock Holding History

Norris Financial Group’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,300
Closed -$6.89K – 68
2020
Q1 		$6.89K Buy
+1,300
New +$9.82K 0.01% 61

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HPWM
Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CWM
Cahaba Wealth Management Atlanta, Georgia $1.47B AUM 13.36% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Norris Financial Group's CATX Position: Q2 2020 in Review

Norris Financial Group sold out of Perspective Therapeutics (CATX) in Q2 2020, closing a stake of 1,300 shares — an estimated $6.89K sold.

Norris Financial Group first reported a position in CATX in Q1 2020 and held it in 1 quarter. The position peaked at $6.89K in Q1 2020. 38 funds tracked by Wall St. Rank hold CATX as of Q2 2020.

  • Norris Financial Group reported no remaining Perspective Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Norris Financial Group sold 1,300 Perspective Therapeutics shares in Q2 2020, an estimated $6.89K.
  • Norris Financial Group first reported a position in Perspective Therapeutics in Q1 2020 and held it in 1 quarter.
  • Norris Financial Group's Perspective Therapeutics position peaked at $6.89K in Q1 2020.
  • 38 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2020.

Based on Norris Financial Group's 13F filing for Q2 2020, filed 2 Jun 2026.